{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:30:37Z","timestamp":1793496637160,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG076649"],"award-info":[{"award-number":["RF1AG076649"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG066749"],"award-info":[{"award-number":["R01-AG066749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG072977"],"award-info":[{"award-number":["P30AG072977"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajpath.2024.10.014","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T18:13:41Z","timestamp":1731262421000},"page":"1988-1997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Amyloid Cascade Hypothesis"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5414-3184","authenticated-orcid":false,"given":"Rudy J.","family":"Castellani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-8589","authenticated-orcid":false,"given":"Pouya","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Plascencia-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6547-0172","authenticated-orcid":false,"given":"George","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.10.014_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.10.014_bib2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2024.10.014_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ajpath.2024.10.014_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib5","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1073\/pnas.1408968111","article-title":"Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice","volume":"111","author":"Stohr","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.10.014_bib6","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1073\/pnas.081553598","article-title":"beta-Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.10.014_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease","volume":"136","author":"Minter","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2024.10.014_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1006\/nbdi.1999.0268","article-title":"Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8","volume":"6","author":"Ivins","year":"1999","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2024.10.014_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity","volume":"130","author":"Varadarajan","year":"2000","journal-title":"J Struct Biol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","article-title":"beta-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding","volume":"14","author":"Busciglio","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s43587-024-00611-5","article-title":"The advent of Alzheimer treatments will change the trajectory of human aging","volume":"4","author":"Selkoe","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.ajpath.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/hmg\/9.18.2589","article-title":"Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease","volume":"9","author":"Kumar-Singh","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2024.10.014_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","article-title":"The genetic defect causing familial Alzheimer's disease maps on chromosome 21","volume":"235","author":"St George-Hyslop","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.10.014_bib15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","article-title":"Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type","volume":"248","author":"Levy","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.10.014_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.10.014_bib17","first-page":"998","article-title":"Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region","volume":"51","author":"Kamino","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2024.10.014_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng0692-218","article-title":"Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene","volume":"1","author":"Hendriks","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2024.10.014_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4161\/cib.21799","article-title":"A protective mutation against Alzheimer disease?","volume":"5","author":"Proft","year":"2012","journal-title":"Commun Integr Biol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.10.014_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","article-title":"Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity","volume":"398","author":"Wolfe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.10.014_bib24","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1074\/jbc.275.5.3173","article-title":"The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation","volume":"275","author":"Kimberly","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.10.014_bib25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2024.10.014_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down's syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial trisomy 21, and absence of Alzheimer's disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2024.10.014_bib29","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1073\/pnas.84.16.5991","article-title":"Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease","volume":"84","author":"van Duinen","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.10.014_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1750-3639.1996.tb00793.x","article-title":"Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I--a review of clinical, radiologic and genetic aspects","volume":"6","author":"Bornebroek","year":"1996","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.1991.tb00208.x","article-title":"Hereditary cerebral hemorrhage with amyloidosis--Dutch type: a congophilic angiopathy: an overview","volume":"640","author":"Roos","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajpath.2024.10.014_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00310382","article-title":"Hereditary cerebral hemorrhage with amyloidosis (Dutch): a model for congophilic plaque formation without neurofibrillary pathology","volume":"88","author":"Maat-Schieman","year":"1994","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.410250104","article-title":"Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds","volume":"25","author":"Bird","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archneurol.2010.178","article-title":"Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP","volume":"67","author":"Bugiani","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.1009","article-title":"Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy","volume":"49","author":"Grabowski","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-020-0891-3","article-title":"Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease","volume":"8","author":"Lloyd","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ajpath.2024.10.014_bib37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-2012-120172","article-title":"The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers","volume":"30","author":"Wallon","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2024.10.014_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.20083","article-title":"A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques","volume":"55","author":"Dermaut","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib39","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/acs.jpcb.2c01769","article-title":"Amyloid beta dodecamer disrupts the neuronal membrane more strongly than the mature fibril: understanding the role of oligomers in neurotoxicity","volume":"126","author":"Nguyen","year":"2022","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.ajpath.2024.10.014_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nchem.247","article-title":"Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease","volume":"1","author":"Bernstein","year":"2009","journal-title":"Nat Chem"},{"key":"10.1016\/j.ajpath.2024.10.014_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/srep28781","article-title":"Common molecular mechanism of amyloid pore formation by Alzheimer's beta-amyloid peptide and alpha-synuclein","volume":"6","author":"Di Scala","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.10.014_bib42","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid beta-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.10.014_bib43","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2024.10.014_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000005807","article-title":"Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: emerging mechanisms","volume":"91","author":"Benarroch","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2024.10.014_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12883-018-1187-0","article-title":"Is traumatic brain injury a risk factor for neurodegeneration? a meta-analysis of population-based studies","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","article-title":"Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls","volume":"73","author":"Esparza","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib47","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"Koffie","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.10.014_bib48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1105850","article-title":"Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils","volume":"307","author":"Petkova","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.10.014_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-011-0912-1","article-title":"The presence of Abeta seeds, and not age per se, is critical to the initiation of Abeta deposition in the brain","volume":"123","author":"Hamaguchi","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","article-title":"Rapidly progressive Alzheimer's disease features distinct structures of amyloid-beta","volume":"138","author":"Cohen","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2024.10.014_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib52","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41374-019-0231-z","article-title":"The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation","volume":"99","author":"Castellani","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2024.10.014_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","article-title":"Multifaceted roles of APOE in Alzheimer disease","volume":"20","author":"Jackson","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2024.10.014_bib55","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.10.014_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.10.014_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib58","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib60","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41408-021-00486-4","article-title":"Comprehensive review of AL amyloidosis: some practical recommendations","volume":"11","author":"Al Hamed","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.ajpath.2024.10.014_bib62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bjsports-2023-106890","article-title":"Examining later-in-life health risks associated with sport-related concussion and repetitive head impacts: a systematic review of case-control and cohort studies","volume":"57","author":"Iverson","year":"2023","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2024.10.014_bib65","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of gantenerumab in early Alzheimer's disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib66","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/brain\/awz142","article-title":"Persistent neuropathological effects 14 years following amyloid-beta immunization in Alzheimer's disease","volume":"142","author":"Nicoll","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2024.10.014_bib67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":"Neuropathology after active A\u03b242 immunotherapy: implications for Alzheimer\u2019s disease pathogenesis","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib68","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","article-title":"Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials","volume":"5","author":"Andrews","year":"2019","journal-title":"Alzheimers Dement (NY)"},{"key":"10.1016\/j.ajpath.2024.10.014_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt7","article-title":"Persistent treatment with cholinesterase inhibitors and\/or memantine slows clinical progression of Alzheimer disease","volume":"1","author":"Rountree","year":"2009","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ajpath.2024.10.014_bib70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jgs.15069","article-title":"Comparative effectiveness and safety of cognitive enhancers for treating Alzheimer's disease: systematic review and network metaanalysis","volume":"66","author":"Tricco","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ajpath.2024.10.014_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053012","article-title":"Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis","volume":"12","author":"Veroniki","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajpath.2024.10.014_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073892","article-title":"Alzheimer's amyloid hypothesis and antibody therapy: melting glaciers?","volume":"25","author":"Hoilund-Carlsen","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.10.014_bib73","doi-asserted-by":"crossref","first-page":"943","DOI":"10.17219\/acem\/171379","article-title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease","volume":"32","author":"Kurkinen","year":"2023","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102348","article-title":"Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit","volume":"99","author":"Hoilund-Carlsen","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ajpath.2024.10.014_bib75","doi-asserted-by":"crossref","first-page":"e2114","DOI":"10.1212\/WNL.0000000000207156","article-title":"Accelerated brain volume loss caused by anti-beta-amyloid drugs: a systematic review and meta-analysis","volume":"100","author":"Alves","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2024.10.014_bib76","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMc2215148","article-title":"Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke","volume":"388","author":"Reish","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.10.014_bib77","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1038\/s41467-023-43933-5","article-title":"Fatal iatrogenic cerebral beta-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer's disease","volume":"14","author":"Solopova","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.10.014_bib78","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3233\/JAD-221305","article-title":"Neuropathology of anti-amyloid-beta immunotherapy: a case report","volume":"93","author":"Castellani","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2024.10.014_bib79","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/awn256","article-title":"Oskar Fischer and the study of dementia","volume":"132","author":"Goedert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2024.10.014_bib80","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","article-title":"Auguste D and Alzheimer's disease","volume":"349","author":"Maurer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2024.10.014_bib81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnen\/nlac030","article-title":"A history of senile plaques: from Alzheimer to amyloid imaging","volume":"81","author":"Beach","year":"2022","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0079-6123(08)60686-X","article-title":"Morphology of the aging brain, human and animal","volume":"40","author":"Wi\u015bniewski","year":"1973","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.ajpath.2024.10.014_bib83","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer disease","volume":"65","author":"Nunomura","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2024.10.014_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad175","article-title":"Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease","volume":"5","author":"Liu","year":"2023","journal-title":"Brain Commun"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024004073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024004073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:21:58Z","timestamp":1793496118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024004073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0002944024004073"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.10.014","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Amyloid Cascade Hypothesis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}